Document is current

Article History

Accepted: 21 January 2025

First Online: 22 February 2025

Declarations

:

: This study was supported by Bristol Myers Squibb.

: NC and RL are employed by Adelphi Values, a consultancy that receives income from pharmaceutical industry clients, including Bristol Myers Squibb. AT was an employee of Adelphi Values at the time of the project, currently employed by Bayer plc. EBT and RTW are employees and shareholders of Bristol Myers Squibb. LO was an employee and shareholder of Bristol Myers Squibb during the project, currently employed by Gilead. JWS was an employee and shareholder of Bristol Myers Squibb during the project. BB was an employee and shareholder of Bristol Myers Squibb during the project, currently employed by Jazz Pharmaceuticals. LS declares no conflicts of interest. JWS is a member of the EuroQoL group.

: All data underlying this article were provided by Bristol Myers Squibb. Bristol Myers Squibb’s policy on data sharing may be found online at: .

: Not applicable.

: Not applicable.

: Not applicable.

: Not applicable.

: All authors contributed to the following activities: Interpretation, reviewing, editing and approval. The study was conceived by EBT, LO, RL, AT, BB, JWS. Acquisition of data: JWS. The first draft of the manuscript was prepared by EBT. Statistical analysis by NC, RL, AT. Obtaining funding: BB. All authors have read and approved the manuscript for submission.